IP Verse

High Potency Pancreatin Pharmaceutical Compositions - EP3024479

The patent EP3024479 was granted to Allergan Pharmaceuticals on Feb 8, 2023. The application was originally filed on Jul 15, 2014 under application number EP14815008A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3024479

ALLERGAN PHARMACEUTICALS
Application Number
EP14815008A
Filing Date
Jul 15, 2014
Status
Patent Maintained As Amended
Jan 6, 2023
Grant Date
Feb 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREMar 5, 2020MATHYS & SQUIREADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2001046493
DESCRIPTIONUS2004057944
DESCRIPTIONUS6051220
DESCRIPTIONWO2006044529
INTERNATIONAL-SEARCH-REPORTCA2419572
INTERNATIONAL-SEARCH-REPORTEP0115023
INTERNATIONAL-SEARCH-REPORTUS2004057944
INTERNATIONAL-SEARCH-REPORTUS2006198838
OPPOSITIONUS3168448
OPPOSITIONUS3223594
OPPOSITIONWO2015069677

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Pancreatic replaces digestive enzymes in patients with pancreatic disorders", Nordmark, (20200228), page 1, XP055709761
OPPOSITION- "Differential precipitations of proteins", Harrison R., Protein Purification Process Engineering, (19940000), pages 135 - 155, XP055709736
OPPOSITION- SHERMAN et al., "ENZYME PURIFICATION : FURTHER EXPERIMENTS WITH PANCREATIC AMYLASE", J. Biol. Chem., (19300000), vol. 88, pages 295 - 304, XP055709700
OPPOSITION- SHERMAN ET AL.: "ENZYME PURIFICATION : FURTHER EXPERIMENTS WITH PANCREATIC AMYLASE", J. BIOL. CHEM., vol. 88, 1930, pages 295 - 304
OPPOSITION- HWANG et al., "Selective Precipitation of Proteins from Pancreatin Using Designed Antisolvents", Ind. Eng. Chem. Res., (20070000), vol. 46, pages 4289 - 4294, XP055169811
OPPOSITION- TRANG et al., "Selective Precipitation of Proteins from Pancreatin Using Designed Antisolvents", World J. Gastroenterol., (20140000), vol. 20, no. 33, pages 11467 - 11485, XP055169811
OPPOSITION- FORSMARK et al., "Pancreatic function testing - valuable but underused", Can. J. Gastroenterol., (20090000), vol. 23, no. 8, pages 529 - 530, XP055709712
OPPOSITION- Tony Trang et al., "Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21 st century", World Journal of Gastroenterology, (2014), vol. 20, no. 33, pages 11467 - 11485, XP055341778

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents